Phase II/III study of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer:NRG-GI005 (COBRA).

作者: Van K Morris , Greg Yothers , Scott Kopetz , Samuel A Jacobs , Peter C Lucas

DOI: 10.1200/JCO.2021.39.3_SUPPL.TPS148

关键词:

摘要: TPS148Background: There are currently no validated predictive biomarkers for stage II resected colon cancer (CC) after adjuvant chemotherapy. However, circulating tumor DNA (ctDNA) that is shed int...

参考文章(0)